New drug ENA-001 takes first step: safety check in healthy volunteers
NCT ID NCT06967259
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tests whether a new drug called ENA-001 is safe in healthy adults. It involves 36 volunteers who receive either the drug or a placebo by injection. The goal is to check for side effects and how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinilabs
ACTIVE_NOT_RECRUITINGEatontown, New Jersey, 07724, United States
-
Dr. Vince Clinical Research
COMPLETEDOverland Park, Kansas, 66212, United States
-
South Florida Research Phase I-IV
RECRUITINGMiami, Florida, 33166, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.